Lenacapavir injection offers 100% HIV protection to young women

Hindustan Times July 7, 2024, 03:00 PM UTC

Summary: A clinical trial in South Africa and Uganda showed that lenacapavir injection offers total protection against HIV for young women, with a 100% efficiency rate. The trial compared lenacapavir to two other PrEP drugs, Truvada and Descovy. The breakthrough could significantly impact HIV prevention efforts, especially for populations at high risk. The drug's rollout is pending regulatory approvals and WHO recommendations. Price and accessibility are crucial considerations for widespread adoption.

Full article

Article metrics
Significance5.8
Scale & Impact0.0
Positivity9.0
Credibility7.3

What is this?

This is article metrics. Combined, they form a significance score, that indicates how important the news is on a scale from 0 to 10.

My algorithm scores 10,000 news articles daily, and creates a single significance-ordered list of news.

Read more about how I calculate significance, or see today's top ranked news on the main page:

See today's news rankings

Timeline:

  1. [4.4]
    Biannual lenacapavir injection 100% effective in preventing HIV (News Karnataka)
    99d 16h
    Source
  2. [5.1]
    UNAIDS urges global access to new HIV drug Lenacapavir (Marketscreener.com)
    102d 18h

  3. [6.3]
    New HIV prevention drug lenacapavir shows 100% efficacy (ScienceAlert)
    103d 19h

  4. [4.6]
    Biannual Lenacapavir injection 100% effective against HIV (WION)
    105d 18h
    Source
  5. [5.2]
    HIV prevention drug lenacapavir safe and effective in trial (The East African)
    107d 13h

  6. [6.1]
    HIV prevention injection successful in South Africa trial (AllAfrica - Top Africa News)
    112d 16h